Literature DB >> 18475509

Phospholipid derived mediators and glomerulonephritis.

E N Wardle1.   

Abstract

The contributions made by the various eicosanoids, PAF, the HETES and the lipoxins to the pathophysiology of glomerulonephritis is reviewed. A case can be made for clinical trials of PAF, leukotriene and thromboxane antagonists. Combined thromboxane synthetase and thromboxane receptor antagonism would seem to be the more efficacious approach for the various disease entities.

Entities:  

Year:  1993        PMID: 18475509      PMCID: PMC2365393          DOI: 10.1155/S0962935193000134

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  44 in total

1.  Lipocortin: what is it and what does it mean?

Authors:  R J Flower
Journal:  Br J Rheumatol       Date:  1992-08

Review 2.  TGF-beta: regulation of extracellular matrix.

Authors:  A B Roberts; B K McCune; M B Sporn
Journal:  Kidney Int       Date:  1992-03       Impact factor: 10.612

3.  Thromboxane mediates glomerular haemodynamics in a model of chronic glomerular disease.

Authors:  F Thaiss; M J Mihatsch; W Schoeppe; R A Stahl
Journal:  Eur J Clin Invest       Date:  1992-03       Impact factor: 4.686

4.  Relationship between hepatic lipid peroxidation and fibrogenesis in carbon tetrachloride-treated rats: effect of zinc administration.

Authors:  J Camps; T Bargallo; A Gimenez; S Alie; J Caballeria; A Pares; J Joven; L Masana; J Rodes
Journal:  Clin Sci (Lond)       Date:  1992-12       Impact factor: 6.124

5.  Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.

Authors:  K Takahashi; T M Nammour; M Fukunaga; J Ebert; J D Morrow; L J Roberts; R L Hoover; K F Badr
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  Thromboxane receptor blockade reduces renal injury in murine lupus nephritis.

Authors:  R F Spurney; P Y Fan; P Ruiz; F Sanfilippo; D S Pisetsky; T M Coffman
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

7.  Contribution of platelet thromboxane production to enhanced urinary excretion and glomerular production of thromboxane and to the pathogenesis of albuminuria in the streptozotocin-diabetic rat.

Authors:  F R DeRubertis; P A Craven
Journal:  Metabolism       Date:  1992-01       Impact factor: 8.694

8.  Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.

Authors:  M Praga; E Hernández; C Montoyo; A Andrés; L M Ruilope; J L Rodicio
Journal:  Am J Kidney Dis       Date:  1992-09       Impact factor: 8.860

9.  Thromboxane augmentation of alloreactive T cell function.

Authors:  P Ruiz; L Rey; R Spurney; T Coffman; A Viciana
Journal:  Transplantation       Date:  1992-09       Impact factor: 4.939

10.  Renal hemodynamic actions of lipoxins in rats: a comparative physiological study.

Authors:  T Katoh; K Takahashi; D K DeBoer; C N Serhan; K F Badr
Journal:  Am J Physiol       Date:  1992-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.